Amylin in Alcohol Addiction: A Potential New Treatment Target or an Adjuvant to Other Treatments?

Journal: ACS chemical neuroscience

Volume: 

Issue: 

Year of Publication: 

Affiliated Institutions:  Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, Maryland , United States.

Abstract summary 

Amylin is a neuroendocrine hormone with a potential role in addictive disorders, including alcohol use disorder (AUD). In addition to reducing appetitive behavior, amylin has been shown to affect alcohol-related behaviors in rodents. Delineating the biobehavioral correlates of amylin in relation to alcohol seeking and consumption has the potential of identifying new treatment targets for AUD, yet additional translational and human research is needed.

Authors & Co-authors:  Boukabara Farokhnia Leggio

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  3
Identifiers
Doi : 10.1021/acschemneuro.4c00133
SSN : 1948-7193
Study Population
Male,Female
Mesh Terms
Other Terms
Amylin;addiction;alcohol;calcitonin;dopamine;serotonin
Study Design
Study Approach
Country of Study
Publication Country
United States